Tramutola, A. ., Arena, A. ., Cini, C. ., Butterfield, D. ., & Barone, E. . (2017). Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology. Expert Review of Neurotherapeutics, 17(1), 59-75. https://doi.org/10.1080/14737175.2017.1246183

Tramutola, A. ., Lanzillotta, C. ., Di Domenico, F. ., Head, E. ., Butterfield, D. ., Perluigi, M. ., & Barone, E. . (2020). Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiology of Disease, 137, 104772. https://doi.org/10.1016/j.nbd.2020.104772

Barone, E. ., Di Domenico, F. ., Cassano, T. ., Arena, A. ., Tramutola, A. ., Lavecchia, M. ., … Perluigi, M. . (2016). Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radical Biology & Medicine, 91, 127-42. https://doi.org/10.1016/j.freeradbiomed.2015.12.012

Tramutola, A. ., Di Domenico, F. ., Barone, E. ., Perluigi, M. ., & Butterfield, D. . It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease. Oxidative Medicine and Cellular Longevity, 2016, 2756068. https://doi.org/10.1155/2016/2756068 (Original work published 2016)

Tramutola, A. ., Pupo, G. ., Di Domenico, F. ., Barone, E. ., Arena, A. ., Lanzillotta, C. ., … Perluigi, M. . Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal of Alzheimer’s Disease : JAD, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)

Perluigi, M. ., Barone, E. ., Di Domenico, F. ., & Butterfield, D. . (2016). Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways. Biochimica Et Biophysica Acta, 1862(10), 1871-82. https://doi.org/10.1016/j.bbadis.2016.07.005

Barone, E. ., Head, E. ., Butterfield, D. ., & Perluigi, M. . (2017). HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology. Free Radical Biology & Medicine, 111, 262-269. https://doi.org/10.1016/j.freeradbiomed.2016.10.508

Barone, E. ., Arena, A. ., Head, E. ., Butterfield, D. ., & Perluigi, M. . (2018). Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism. Free Radical Biology & Medicine, 114, 84-93. https://doi.org/10.1016/j.freeradbiomed.2017.07.009

Barone, E. ., Mancuso, C. ., Di Domenico, F. ., Sultana, R. ., Murphy, M. ., Head, E. ., & Butterfield, D. . (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x

Cenini, G. ., Dowling, A. ., Beckett, T. ., Barone, E. ., Mancuso, C. ., Murphy, M. ., … Head, E. . (2012). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica Et Biophysica Acta, 1822(2), 130-8. https://doi.org/10.1016/j.bbadis.2011.10.001